User menu

The central role of extracellular vesicles in the mechanisms of thrombosis in paroxysmal nocturnal haemoglobinuria: a review.

Bibliographic reference DEVALET, Bérangère ; Mullier, François ; Chatelain, Bernard ; Dogné, Jean-Michel ; Chatelain, Christian. The central role of extracellular vesicles in the mechanisms of thrombosis in paroxysmal nocturnal haemoglobinuria: a review.. In: Journal of Extracellular Vesicles, Vol. 3 (2014)
Permanent URL
  1. DAMESHEK WILLIAM, Paroxysmal Nocturnal Hemoglobinuria : Atypical Manifestations Suggesting an Immunologic Disease, 10.1001/archinte.1957.00260020038006
  2. Shi Q, Blood, 92, 362 (1998)
  3. Parker CJ, Hematology Am Soc Hematol Educ Program, 2011, 21 (2011)
  4. Weitz Ilene, Thrombosis in Patients with Paroxysmal Nocturnal Hemoglobinuria, 10.1055/s-0031-1273095
  5. Schubert Jrg, Hillmen Peter, Rth Alexander, Young Neal S., Elebute Modupe O., Szer Jeffrey, Gianfaldoni Giacomo, Soci Grard, Browne Paul, Geller Robert, Rother Russell P., Muus Petra, Eculizumab, a terminal complement inhibitor, improves anaemia in patients with paroxysmal nocturnal haemoglobinuria, 10.1111/j.1365-2141.2008.07183.x
  6. Brodsky R. A., Young N. S., Antonioli E., Risitano A. M., Schrezenmeier H., Schubert J., Gaya A., Coyle L., de Castro C., Fu C.-L., Maciejewski J. P., Bessler M., Kroon H.-A., Rother R. P., Hillmen P., Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria, 10.1182/blood-2007-06-094136
  7. Hillmen Peter, Elebute Modupe, Kelly Richard, Urbano-Ispizua Alvaro, Hill Anita, Rother Russell P., Khursigara Gus, Fu Chieh-Lin, Omine Mitsuhiro, Browne Paul, Rosse Wendell, Long-term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria, 10.1002/ajh.21757
  8. Kelly R. J., Hill A., Arnold L. M., Brooksbank G. L., Richards S. J., Cullen M., Mitchell L. D., Cohen D. R., Gregory W. M., Hillmen P., Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival, 10.1182/blood-2011-02-333997
  9. Hillmen P., Muus P., Duhrsen U., Risitano A. M., Schubert J., Luzzatto L., Schrezenmeier H., Szer J., Brodsky R. A., Hill A., Socie G., Bessler M., Rollins S. A., Bell L., Rother R. P., Young N. S., Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria, 10.1182/blood-2007-06-095646
  10. Weitz Ilene C., Razavi Pedram, Rochanda Leanne, Zwicker Jeffrey, Furie Bruce, Manly David, Mackman Nigel, Green Ralph, Liebman Howard A., Eculizumab therapy results in rapid and sustained decreases in markers of thrombin generation and inflammation in patients with PNH independent of its effects on hemolysis and microparticle formation, 10.1016/j.thromres.2012.04.001
  11. Helley D., de Latour R. P., Porcher R., Rodrigues C. A., Galy-Fauroux I., Matheron J., Duval A., Schved J. F., Fischer A. M., Socie G., , Evaluation of hemostasis and endothelial function in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab, 10.3324/haematol.2009.016121
  12. Malato A, Blood Transfus, 10, 428 (2012)
  13. ZIAKAS P. D., POULOU L. S., ROKAS G. I., BARTZOUDIS D., VOULGARELIS M., Thrombosis in paroxysmal nocturnal hemoglobinuria: sites, risks, outcome. An overview, 10.1111/j.1538-7836.2007.02379.x
  14. Araten DJ, Thromb Haemost, 93, 88 (2005)
  15. de Latour R. P., Mary J. Y., Salanoubat C., Terriou L., Etienne G., Mohty M., Roth S., de Guibert S., Maury S., Cahn J. Y., Socie G., , Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories, 10.1182/blood-2008-01-133918
  16. Audebert H., Planck J., Eisenburg M., Schrezenmeier H., Haberl R. L., Cerebral Ischemic Infarction in Paroxysmal Nocturnal Hemoglobinuria : Report of 2 Cases and Updated Review of 7 Previously Published Patients, 10.1007/s00415-005-0871-3
  17. György Bence, Szabó Tamás G., Pásztói Mária, Pál Zsuzsanna, Misják Petra, Aradi Borbála, László Valéria, Pállinger Éva, Pap Erna, Kittel Ágnes, Nagy György, Falus András, Buzás Edit I., Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles, 10.1007/s00018-011-0689-3
  18. Lacroix R., Dubois C., Leroyer A. S., Sabatier F., Dignat-George F., Revisited role of microparticles in arterial and venous thrombosis, 10.1111/jth.12268
  19. Morel O., Jesel L., Freyssinet J.-M., Toti F., Cellular Mechanisms Underlying the Formation of Circulating Microparticles, 10.1161/atvbaha.109.200956
  20. Sinauridze EI, Thromb Haemost, 97, 425 (2007)
  21. Burnier L, Thromb Haemost, 101, 439 (2009)
  22. Piccin Andrea, Murphy William G., Smith Owen P., Circulating microparticles: pathophysiology and clinical implications, 10.1016/j.blre.2006.09.001
  23. Bevers EM, Blood, 79, 380 (1992)
  24. Owens A. P., Mackman N., Microparticles in Hemostasis and Thrombosis, 10.1161/circresaha.110.233056
  25. BIDOT L., JY W., BIDOT C., JIMENEZ J. J., FONTANA V., HORSTMAN L. L., AHN Y. S., Microparticle-mediated thrombin generation assay: increased activity in patients with recurrent thrombosis, 10.1111/j.1538-7836.2008.02963.x
  26. Østerud Bjarne, Tissue factor expression in blood cells, 10.1016/j.thromres.2010.01.032
  27. del Conde I., Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation, 10.1182/blood-2004-03-1095
  28. Owens A. Phillip, Mackman Nigel, Role of Tissue Factor in Atherothrombosis, 10.1007/s11883-012-0269-5
  29. Geddings J. E., Mackman N., Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients, 10.1182/blood-2013-04-460139
  30. Langer F, Thromb Haemost, 111 (2014)
  31. Collier M. E. W., Mah P.-M., Xiao Y., Maraveyas A., Ettelaie C., Microparticle-associated tissue factor is recycled by endothelial cells resulting in enhanced surface tissue factor activity : , 10.1160/th13-01-0055
  32. Davila M., Robles-Carrillo L., Unruh D., Huo Q., Gardiner C., Sargent I. L., Adam M., Woodhams B. J., Francis J. L., Bogdanov V. Y., Amirkhosravi A., Microparticle association and heterogeneity of tumor-derived tissue factor in plasma: is it important for coagulation activation?, 10.1111/jth.12475
  33. Gheldof Damien, Hardij Julie, Cecchet Francesca, Chatelain Bernard, Dogné Jean-Michel, Mullier François, Thrombin generation assay and transmission electron microscopy: a useful combination to study tissue factor-bearing microvesicles, 10.3402/jev.v2i0.19728
  34. Hugel B, Blood, 93, 3451 (1999)
  35. Liebman Howard A, Feinstein Donald I, Thrombosis in patients with paroxysmal noctural hemoglobinuria is associated with markedly elevated plasma levels of leukocyte-derived tissue factor, 10.1016/j.thromres.2003.09.018
  36. VAN BIJNEN S. T. A., VAN HEERDE W. L., MUUS P., Mechanisms and clinical implications of thrombosis in paroxysmal nocturnal hemoglobinuria : Thrombosis in PNH, 10.1111/j.1538-7836.2011.04562.x
  37. Mullier F, Thromb Res (2013)
  38. Gurney David, Lip Gregory Y.H., Blann Andrew D., A reliable plasma marker of platelet activation: Does it exist?, 10.1002/ajh.10097
  39. Yahata T, Circ J, 78, 188 (2013)
  40. Hall C., Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH), 10.1182/blood-2003-01-0009
  42. Kozuma Yukinori, Sawahata Yuka, Takei Yumi, Chiba Shigeru, Ninomiya Haruhiko, Procoagulant properties of microparticles released from red blood cells in paroxysmal nocturnal haemoglobinuria : Procoagulant MP Release from PNH RBC, 10.1111/j.1365-2141.2010.08505.x
  43. Simak Jan, Holada Karel, Risitano Antonio M., Zivny Jan H., Young Neal S., Vostal Jaroslav G., Elevated circulating endothelial membrane microparticles in paroxysmal nocturnal haemoglobinuria, 10.1111/j.1365-2141.2004.04974.x
  44. Schaer D. J., Buehler P. W., Cell-Free Hemoglobin and Its Scavenger Proteins: New Disease Models Leading the Way to Targeted Therapies, 10.1101/cshperspect.a013433
  45. Ritis K., Doumas M., Mastellos D., Micheli A., Giaglis S., Magotti P., Rafail S., Kartalis G., Sideras P., Lambris J. D., A Novel C5a Receptor-Tissue Factor Cross-Talk in Neutrophils Links Innate Immunity to Coagulation Pathways, 10.4049/jimmunol.177.7.4794
  46. Huber-Lang Markus, Sarma J Vidya, Zetoune Firas S, Rittirsch Daniel, Neff Thomas A, McGuire Stephanie R, Lambris John D, Warner Roscoe L, Flierl Michael A, Hoesel Laszlo M, Gebhard Florian, Younger John G, Drouin Scott M, Wetsel Rick A, Ward Peter A, Generation of C5a in the absence of C3: a new complement activation pathway, 10.1038/nm1419
  47. Steppich B, Thromb Haemost, 93, 35 (2005)
  48. Jankowska A. M., Szpurka H., Calabro M., Mohan S., Schade A. E., Clemente M., Silverstein R. L., Maciejewski J. P., Loss of expression of neutrophil proteinase-3: a factor contributing to thrombotic risk in paroxysmal nocturnal hemoglobinuria, 10.3324/haematol.2010.029298
  49. Dragoni F, Br J Haematol, 150, 492 (2010)
  50. Grünewald Martin, Siegemund Annelie, Grünewald Anja, Schmid Anke, Koksch Mario, Schöpflin Christine, Schauer Stefanie, Griesshammer Martin, Plasmatic coagulation and fibrinolytic system alterations in PNH : relation to clone size, 10.1097/00001721-200310000-00011
  51. Plesner T., Behrendt N., Ploug M., Structure, Function and Expression on Blood and Bone Marrow Cells of the Urokinase‐Type Plasminogen Activator Receptor, uPAR, 10.1002/stem.150398
  52. Sloand Elaine M., Pfannes Loretta, Scheinberg Phillip, More Kenneth, Wu Colin O., Horne McDonald, Young Neal S., Increased soluble urokinase plasminogen activator receptor (suPAR) is associated with thrombosis and inhibition of plasmin generation in paroxysmal nocturnal hemoglobinuria (PNH) patients, 10.1016/j.exphem.2008.06.016
  53. PLOUG Michael, ERIKSEN Jens, PLESNER Torben, HANSEN Niels Ebbe, DANO Keld, A soluble form of the glycolipid-anchored receptor for urokinase-type plasminogen activator is secreted from peripheral blood leukocytes from patients with paroxysmal nocturnal hemoglobinuria, 10.1111/j.1432-1033.1992.tb17200.x
  54. Ginestra Angela, Monea Sara, Seghezzi Graziano, Dolo Vincenza, Nagase Hideaki, Mignatti Paolo, Vittorelli M. Letizia, Urokinase Plasminogen Activator and Gelatinases Are Associated with Membrane Vesicles Shed by Human HT1080 Fibrosarcoma Cells, 10.1074/jbc.272.27.17216
  55. Ginestra A, Anticancer Res, 19, 3439 (1999)
  56. Angelucci Adriano, D'Ascenzo Sandra, Festuccia Claudio, Gravina Giovanni Luca, Bologna Mauro, Dolo Vincenza, Pavan Antonio, 10.1023/a:1006778000173
  57. Lacroix R., Sabatier F., Mialhe A., Basire A., Pannell R., Borghi H., Robert S., Lamy E., Plawinski L., Camoin-Jau L., Gurewich V., Angles-Cano E., Dignat-George F., Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro, 10.1182/blood-2007-02-069997
  58. Kwaan Hau, Magalhães Rego Eduardo, Role of Microparticles in the Hemostatic Dysfunction in Acute Promyelocytic Leukemia, 10.1055/s-0030-1267045
  59. Rao Sunil V., Relationship of Blood Transfusion and Clinical Outcomes in Patients With Acute Coronary Syndromes, 10.1001/jama.292.13.1555
  60. Khorana Alok A., Francis Charles W., Blumberg Neil, Culakova Eva, Refaai Majed A., Lyman Gary H., Blood Transfusions, Thrombosis, and Mortality in Hospitalized Patients With Cancer, 10.1001/archinte.168.21.2377
  61. Abu-Rustum Nadeem R., Richard Scott, Wilton Andrew, Lev Gali, Sonoda Yukio, Hensley Martee L., Gemignani Mary, Barakat Richard R., Chi Dennis S., Transfusion utilization during adnexal or peritoneal cancer surgery: Effects on symptomatic venous thromboembolism and survival, 10.1016/j.ygyno.2005.06.017
  62. Nilsson Kent R., Association Between Venous Thromboembolism and Perioperative Allogeneic Transfusion, 10.1001/archsurg.142.2.126
  63. Tan Tze-Woei, Farber Alik, Hamburg Naomi M., Eberhardt Robert T., Rybin Denis, Doros Gheorghe, Eldrup-Jorgensen Jens, Goodney Philip P., Cronenwett Jack L., Kalish Jeffrey A., Blood Transfusion for Lower Extremity Bypass Is Associated with Increased Wound Infection and Graft Thrombosis, 10.1016/j.jamcollsurg.2013.01.006
  64. Kumar Monisha A., Boland Torrey A., Baiou Mohamed, Moussouttas Michael, Herman Jay H., Bell Rodney D., Rosenwasser Robert H., Kasner Scott E., Dechant Valerie E., Red Blood Cell Transfusion Increases the Risk of Thrombotic Events in Patients with Subarachnoid Hemorrhage, 10.1007/s12028-013-9819-0
  65. Rubin Olivier, Delobel Julien, Prudent Michel, Lion Niels, Kohl Kid, Tucker Erik I., Tissot Jean-Daniel, Angelillo-Scherrer Anne, Red blood cell-derived microparticles isolated from blood units initiate and propagate thrombin generation : RMPs Generate Thrombin, 10.1111/trf.12008
  66. Spinella PC, Crit Care, 13 (2009)
  67. Moyo Victor M., Mukhina Galina L., Garrett Elizabeth S., Brodsky Robert A., Natural history of paroxysmal nocturnal haemoglobinuria using modern diagnostic assays, 10.1111/j.1365-2141.2004.04992.x
  68. Robert S., Lacroix R., Poncelet P., Harhouri K., Bouriche T., Judicone C., Wischhusen J., Arnaud L., Dignat-George F., High-Sensitivity Flow Cytometry Provides Access to Standardized Measurement of Small-Size Microparticles--Brief Report, 10.1161/atvbaha.111.244616
  69. LACROIX R., JUDICONE C., PONCELET P., ROBERT S., ARNAUD L., SAMPOL J., DIGNAT-GEORGE F., Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol : Pre-analytics influence on microparticles analysis, 10.1111/j.1538-7836.2011.04610.x
  70. LACROIX R., ROBERT S., PONCELET P., KASTHURI R. S., KEY N. S., DIGNAT-GEORGE F., , Standardization of platelet-derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop : Standardization of platelet-derived microparticle enumeration by flow cytometry, 10.1111/j.1538-7836.2010.04047.x
  71. Mullier F., Bailly N., Chatelain C., Chatelain B., Dogné J.-M., Pre-analytical issues in the measurement of circulating microparticles: current recommendations and pending questions, 10.1111/jth.12171